Vor Bio

About Vor Bio

Vor Bio is a clinical-stage biotechnology company focused on transforming the treatment of autoimmune diseases. Their mission is to deliver life-changing therapies to patients worldwide with serious, autoantibody-driven conditions.

Products & Services

Telitacicept:A novel, dual-target recombinant fusion protein that inhibits BLyS (BAFF) and APRIL, reducing autoreactive B cells and autoantibody production. It is approved in China for systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and generalized myasthenia gravis (gMG). A global Phase 3 trial for gMG is underway in the US, Europe, and South America.

Specialties

Cell and Genome Engineering Autoimmune Disease Treatment Dual-target Recombinant Fusion Proteins

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Private Placement T: - FT: Private Placement	A: 150000000 MR: - FA: 150 million FAN: 150000000	D: 2025-12-15 FD: 2025-12-15	6 investors
2	RT: Public Offering T: - FT: Public Offering	A: 100000000 MR: - FA: $100 million FAN: 100000000	D: 2025-11-10 FD: 2025-11-10	4 investors
3	RT: Private Placement T: - FT: Private Placement	A: 175000000 MR: - FA: $175 million FAN: 175000000	D: 2025-06-25 FD: 2025-06-25	6 investors
4	RT: PIPE T: - FT: PIPE	A: 55600000 MR: - FA: $55.6 million FAN: 55600000	D: 2024-12-30 FD: 2024-12-30	2 investors

Private Placement Latest

2025-12-15

$150.0M

6 investors (Pro only)

Public Offering 2025-11-10

$100.0M

Private Placement 2025-06-25

$175.0M

View 3 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Jean-Paul Kress

CEO and Chairman

LinkedIn (Pro only)

Recent News

Vor Bio Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised